136 related articles for article (PubMed ID: 27022716)
1. Microwave-driven Synthesis of Iron Oxide Nanoparticles for Fast Detection of Atherosclerosis.
Pellico J; Ruiz-Cabello J; Herranz F
J Vis Exp; 2016 Mar; (109):. PubMed ID: 27022716
[TBL] [Abstract][Full Text] [Related]
2. Key Parameters on the Microwave Assisted Synthesis of Magnetic Nanoparticles for MRI Contrast Agents.
Brollo MEF; Veintemillas-Verdaguer S; Salván CM; Morales MDP
Contrast Media Mol Imaging; 2017; 2017():8902424. PubMed ID: 29348738
[TBL] [Abstract][Full Text] [Related]
3. Microwave-Driven Synthesis of Iron-Oxide Nanoparticles for Molecular Imaging.
Fernández-Barahona I; Muñoz-Hernando M; Herranz F
Molecules; 2019 Mar; 24(7):. PubMed ID: 30925778
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of 68Ga Core-doped Iron Oxide Nanoparticles for Dual Positron Emission Tomography /(T1)Magnetic Resonance Imaging.
Fernández-Barahona I; Ruiz-Cabello J; Herranz F; Pellico J
J Vis Exp; 2018 Nov; (141):. PubMed ID: 30531725
[TBL] [Abstract][Full Text] [Related]
5. Imaging monocytes with iron oxide nanoparticles targeted towards the monocyte integrin MAC-1 (CD11b/CD18) does not result in improved atherosclerotic plaque detection by in vivo MRI.
von zur Muhlen C; Fink-Petri A; Salaklang J; Paul D; Neudorfer I; Berti V; Merkle A; Peter K; Bode C; von Elverfeldt D
Contrast Media Mol Imaging; 2010; 5(5):268-75. PubMed ID: 20973112
[TBL] [Abstract][Full Text] [Related]
6. Surface-Functionalized Nanoparticles by Olefin Metathesis: A Chemoselective Approach for In Vivo Characterization of Atherosclerosis Plaque.
Salinas B; Ruiz-Cabello J; Lechuga-Vieco AV; Benito M; Herranz F
Chemistry; 2015 Jul; 21(29):10450-6. PubMed ID: 26096657
[TBL] [Abstract][Full Text] [Related]
7. Hot-injection synthesis of iron/iron oxide core/shell nanoparticles for T2 contrast enhancement in magnetic resonance imaging.
Herman DA; Ferguson P; Cheong S; Hermans IF; Ruck BJ; Allan KM; Prabakar S; Spencer JL; Lendrum CD; Tilley RD
Chem Commun (Camb); 2011 Aug; 47(32):9221-3. PubMed ID: 21761066
[TBL] [Abstract][Full Text] [Related]
8. Fast synthesis and bioconjugation of (68) Ga core-doped extremely small iron oxide nanoparticles for PET/MR imaging.
Pellico J; Ruiz-Cabello J; Saiz-Alía M; Del Rosario G; Caja S; Montoya M; Fernández de Manuel L; Morales MP; Gutiérrez L; Galiana B; Enríquez JA; Herranz F
Contrast Media Mol Imaging; 2016 May; 11(3):203-10. PubMed ID: 26748837
[TBL] [Abstract][Full Text] [Related]
9. Histological validation of iron-oxide and gadolinium based MRI contrast agents in experimental atherosclerosis: the do's and don't's.
den Adel B; Bovens SM; te Boekhorst B; Strijkers GJ; Poelmann RE; van der Weerd L; Pasterkamp G
Atherosclerosis; 2012 Dec; 225(2):274-80. PubMed ID: 22882907
[TBL] [Abstract][Full Text] [Related]
10. Large-Scale, Facile Transfer of Oleic Acid-Stabilized Iron Oxide Nanoparticles to the Aqueous Phase for Biological Applications.
Cai J; Miao YQ; Yu BZ; Ma P; Li L; Fan HM
Langmuir; 2017 Feb; 33(7):1662-1669. PubMed ID: 28146360
[TBL] [Abstract][Full Text] [Related]
11. Large-scale synthesis of uniform and extremely small-sized iron oxide nanoparticles for high-resolution T1 magnetic resonance imaging contrast agents.
Kim BH; Lee N; Kim H; An K; Park YI; Choi Y; Shin K; Lee Y; Kwon SG; Na HB; Park JG; Ahn TY; Kim YW; Moon WK; Choi SH; Hyeon T
J Am Chem Soc; 2011 Aug; 133(32):12624-31. PubMed ID: 21744804
[TBL] [Abstract][Full Text] [Related]
12. Iron Oxide Nanoparticles as Contrast Agents in Molecular Magnetic Resonance Imaging: Do They Open New Perspectives in Cardiovascular Imaging?
Ploussi AG; Gazouli M; Stathis G; Kelekis NL; Efstathopoulos EP
Cardiol Rev; 2015; 23(5):229-35. PubMed ID: 25688663
[TBL] [Abstract][Full Text] [Related]
13. Iron oxide core oil-in-water nanoemulsion as tracer for atherosclerosis MPI and MRI imaging.
Prévot G; Kauss T; Lorenzato C; Gaubert A; Larivière M; Baillet J; Laroche-Traineau J; Jacobin-Valat MJ; Adumeau L; Mornet S; Barthélémy P; Duonor-Cérutti M; Clofent-Sanchez G; Crauste-Manciet S
Int J Pharm; 2017 Nov; 532(2):669-676. PubMed ID: 28899764
[TBL] [Abstract][Full Text] [Related]
14. Magnetic iron oxide nanoparticles as novel and efficient tools for atherosclerosis diagnosis.
Montiel Schneider MG; Lassalle VL
Biomed Pharmacother; 2017 Sep; 93():1098-1115. PubMed ID: 28738519
[TBL] [Abstract][Full Text] [Related]
15. Rapid synthesis of water-dispersible superparamagnetic iron oxide nanoparticles by a microwave-assisted route for safe labeling of endothelial progenitor cells.
Carenza E; Barceló V; Morancho A; Montaner J; Rosell A; Roig A
Acta Biomater; 2014 Aug; 10(8):3775-85. PubMed ID: 24755438
[TBL] [Abstract][Full Text] [Related]
16. Facile preparation of zwitterion-stabilized superparamagnetic iron oxide nanoparticles (ZSPIONs) as an MR contrast agent for in vivo applications.
Kim D; Chae MK; Joo HJ; Jeong IH; Cho JH; Lee C
Langmuir; 2012 Jun; 28(25):9634-9. PubMed ID: 22607014
[TBL] [Abstract][Full Text] [Related]
17. Properties and suspension stability of dendronized iron oxide nanoparticles for MRI applications.
Basly B; Felder-Flesch D; Perriat P; Pourroy G; Bégin-Colin S
Contrast Media Mol Imaging; 2011; 6(3):132-8. PubMed ID: 21698771
[TBL] [Abstract][Full Text] [Related]
18. Designed synthesis of uniformly sized iron oxide nanoparticles for efficient magnetic resonance imaging contrast agents.
Lee N; Hyeon T
Chem Soc Rev; 2012 Apr; 41(7):2575-89. PubMed ID: 22138852
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, self-assembly, and characterization of PEG-coated iron oxide nanoparticles as potential MRI contrast agent.
Yue-Jian C; Juan T; Fei X; Jia-Bi Z; Ning G; Yi-Hua Z; Ye D; Liang G
Drug Dev Ind Pharm; 2010 Oct; 36(10):1235-44. PubMed ID: 20818962
[TBL] [Abstract][Full Text] [Related]
20. Iron Oxide Nanoparticle Based Contrast Agents for Magnetic Resonance Imaging.
Shen Z; Wu A; Chen X
Mol Pharm; 2017 May; 14(5):1352-1364. PubMed ID: 27776215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
